{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:01:40Z","timestamp":1791644500791,"version":"4.3.4"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"Supplement_1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,3,1]]},"abstract":"<jats:p>One of the highest risk periods for seizures during the human life span is the first month of life. Most neonatal seizures are triggered by acute illness such as hypoxic-ischemic encephalopathy, stroke, or infection; rarely are they triggered by epilepsy per se. Seizures are the most common and important sign of acute neonatal encephalopathy, are a major risk for death or subsequent neurologic disability, and by themselves may contribute to an adverse neurodevelopmental outcome. Customary clinical practice includes visual monitoring of high-risk neonates for seizures, performance of a routine electroencephalogram (EEG) for suspicious clinical seizure activity, and empirical treatment with phenobarbital. Presently, however, there are no data that have unequivocally demonstrated the efficacy of barbiturates in the treatment of neonatal seizures. The neurology group recognizes an important need for randomized, placebo-controlled, ethically acceptable trials of phenobarbital efficacy and safety in the treatment of neonatal seizures. After exploring 3 possible frameworks for clinical trials of phenobarbital in the treatment of neonatal seizures, the neurology group ultimately focused on a multicenter, placebo-controlled, electroencephalographer-blinded study of phenobarbital versus placebo in a homogeneous group of newborns who are at high risk of developing early subclinical electroencephalographically detected neonatal seizures. Continuous video-EEG monitoring would establish the presence and number of seizures. Criteria for escape from the study to treatment are clearly defined. The proposed study could provide the first concrete evidence of treatment efficacy because (1) it examines a homogeneous patient population, (2) the recognition and quantification of seizures rests solely on the gold standard of seizure detection (EEG), and (3) the dosing of phenobarbital is matched specifically to the phenobarbital-binding characteristics of the individual treated. This study would affirm or refute the common practice of phenobarbital as the first-line treatment of neonatal seizures.<\/jats:p>","DOI":"10.1542\/peds.2005-0620d","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:12:21Z","timestamp":1774026741000},"page":"S23-S27","source":"Crossref","is-referenced-by-count":6,"title":["Summary Proceedings From the Neurology Group on Neonatal Seizures"],"prefix":"10.1542","volume":"117","author":[{"given":"Robert R.","family":"Clancy","sequence":"first","affiliation":[{"name":"Division of Neurology, University of Pennsylvania School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,3,1]]},"reference":[{"key":"2026032013121837400_R1","doi-asserted-by":"crossref","unstructured":"deVeber G, Chan C, Monagle P, et al. Anticoagulation therapy in pediatric patients with sinovenous thrombosis: a cohort study. Arch Neurol.\u20081998;55:1533\u20131537","DOI":"10.1001\/archneur.55.12.1533"},{"key":"2026032013121837400_R2","doi-asserted-by":"crossref","unstructured":"Eriksson M, Zetterstrom R. Neonatal convulsions: incidence and causes in the Stockholm area. Acta Paediatr Scand.\u20081979;68:807\u2013811","DOI":"10.1111\/j.1651-2227.1979.tb08216.x"},{"key":"2026032013121837400_R3","doi-asserted-by":"crossref","unstructured":"Lanska MJ, Lanska DJ, Baumann RJ, Kryscio RJ. A population-based study of neonatal seizures in Fayette County, Kentucky. Neurology.\u20081995;45:724\u2013732","DOI":"10.1212\/WNL.45.4.724"},{"key":"2026032013121837400_R4","doi-asserted-by":"crossref","unstructured":"Ronen GM, Penney S, Andrews W. The epidemiology of clinical neonatal seizures in Newfoundland: a population-based study. J Pediatr.\u20081999;134:71\u201375","DOI":"10.1016\/S0022-3476(99)70374-4"},{"key":"2026032013121837400_R5","doi-asserted-by":"crossref","unstructured":"Saliba RM, Annegers JF, Waller DK, Tyson JE, Mizrahi EM. Incidence of neonatal seizures in Harris County, Texas, 1992\u20131994. Am J Epidemiol.\u20081996;150:763\u2013769","DOI":"10.1093\/oxfordjournals.aje.a010079"},{"key":"2026032013121837400_R6","doi-asserted-by":"crossref","unstructured":"Leviton A, Nelson KB. Problems with definitions and classifications of newborn encephalopathy. Pediatr Neurol.\u20081992;8:85\u201390","DOI":"10.1016\/0887-8994(92)90026-U"},{"key":"2026032013121837400_R7","doi-asserted-by":"crossref","unstructured":"Bergman I, Painter MJ, Hirsch RP, Crumrine PK, David R. Outcomes in neonates with convulsions treated in an intensive care unit. Ann Neurol.\u20081983;14:642\u2013647","DOI":"10.1002\/ana.410140607"},{"key":"2026032013121837400_R8","doi-asserted-by":"crossref","unstructured":"Ellenberg JH, Nelson KB. Cluster of perinatal events identifying infants at high risk for death or disability. J Pediatr.\u20081988;113:546\u2013552","DOI":"10.1016\/S0022-3476(88)80649-8"},{"key":"2026032013121837400_R9","unstructured":"Legido A, Clancy RR, Berman PH. Neurologic outcome after electroencephalographically proven neonatal seizures. Pediatrics.\u20081991;88:583\u2013596"},{"key":"2026032013121837400_R10","doi-asserted-by":"crossref","unstructured":"Nelson KB, Broman SH. Perinatal risk factors in children with serious motor and mental handicaps. Ann Neurol.\u20081977;2:371\u2013377","DOI":"10.1002\/ana.410020505"},{"key":"2026032013121837400_R11","unstructured":"Mizrahi EM, Clancy R, Dunn JK, et al. Neurologic impairment, developmental delay and post-natal seizures two years after video-EEG documented seizures in near-term and full-term neonates: Report of the Clinical Research Centers for Neonatal Seizures [abstract]. Epilepsia.\u20082001;102:47"},{"key":"2026032013121837400_R12","doi-asserted-by":"crossref","unstructured":"Holmes GL, Gairsa JL, Chevassus-Au-Louis N, Ben-Ari Y. Consequences of neonatal seizures in the rat: morphological and behavioral effects. Ann Neurol.\u20081998;44:845\u2013857","DOI":"10.1002\/ana.410440602"},{"key":"2026032013121837400_R13","doi-asserted-by":"crossref","unstructured":"Holmes GL. Seizure-induced neuronal injury: animal data. Neurology.\u20082002;59(9 suppl 5):S3\u2013S6","DOI":"10.1212\/WNL.59.9_suppl_5.S3"},{"key":"2026032013121837400_R14","doi-asserted-by":"crossref","unstructured":"Miller SP, Weiss J, Barnwell A, et al. Seizure-associated brain injury in term newborns with perinatal asphyxia. Neurology.\u20082002;58:542\u2013548","DOI":"10.1212\/WNL.58.4.542"},{"key":"2026032013121837400_R15","doi-asserted-by":"crossref","unstructured":"Goldberg RN, Moscoso P, Bauer CR, et al. Use of barbiturate therapy in severe perinatal asphyxia: a randomized controlled trial. J Pediatr.\u20081986;109:851\u2013856","DOI":"10.1016\/S0022-3476(86)80713-2"},{"key":"2026032013121837400_R16","doi-asserted-by":"crossref","unstructured":"Hall RT, Hall FK, Daily DK. High-dose phenobarbital therapy in term newborn infants with severe perinatal asphyxia: a randomized, prospective study with three-year follow-up [commentary]. J Pediatr.\u20081998;132:345\u2013348","DOI":"10.1016\/S0022-3476(98)70458-5"},{"key":"2026032013121837400_R17","doi-asserted-by":"crossref","unstructured":"Connell J, Oozeer R, de Vries L, Dubowitz LM, Dubowitz V. Clinical and EEG response to anticonvulsants in neonatal seizures. Arch Dis Child.\u20081989;64:459\u2013464","DOI":"10.1136\/adc.64.4_Spec_No.459"},{"key":"2026032013121837400_R18","doi-asserted-by":"crossref","unstructured":"Bye AM, Flanagan D. Spatial and temporal characteristics of neonatal seizures. Epilepsia.\u20081995;36:1009\u20131016","DOI":"10.1111\/j.1528-1157.1995.tb00960.x"},{"key":"2026032013121837400_R19","doi-asserted-by":"crossref","unstructured":"Boylan GB, Rennie JM, Pressler RM, Wilson G, Morton M, Binnie CD. Phenobarbitone, neonatal seizures, and video-EEG. Arch Dis Child Fetal Neonatal Ed.\u20082002;86:F165\u2013F170","DOI":"10.1136\/fn.86.3.F165"},{"key":"2026032013121837400_R20","doi-asserted-by":"crossref","unstructured":"Painter MJ, Scher MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med.\u20081999;341:485\u2013489","DOI":"10.1056\/NEJM199908123410704"},{"key":"2026032013121837400_R21","doi-asserted-by":"crossref","unstructured":"Evans DJ, Levene MI. Anticonvulsants for preventing mortality and morbidity in full term newborns with perinatal asphyxia. Cochrane Database Syst Rev.\u20082001(3):CD001240","DOI":"10.1002\/14651858.CD001240"},{"key":"2026032013121837400_R22","doi-asserted-by":"crossref","unstructured":"Lago P, Rebsamen S, Clancy R, et al. MRI, MRA, and neurodevelopmental outcome following neonatal ECMO. Pediatr Neurol.\u20081995;12:294\u2013304","DOI":"10.1016\/0887-8994(95)00047-J"},{"key":"2026032013121837400_R23","doi-asserted-by":"crossref","unstructured":"Clancy RR, McGaurn S, Wernovsky G, et al. Risk of seizures in survivors of newborn heart surgery using deep hypothermic circulatory arrest. Pediatrics.\u20082001;111:592\u2013601","DOI":"10.1542\/peds.111.3.592"},{"key":"2026032013121837400_R24","unstructured":"Sharif U, Ichord R, Gaynor JW, et al. Electrographic neonatal seizures after newborn heart surgery [abstract]. Epilepsia.\u20082003;44:164"},{"key":"2026032013121837400_R25","doi-asserted-by":"crossref","unstructured":"Mizrahi EM, Kellaway P. Characterization and classification of neonatal seizures. Neurology.\u20081987;37:1837\u20131844","DOI":"10.1212\/WNL.37.12.1837"},{"key":"2026032013121837400_R26","doi-asserted-by":"crossref","unstructured":"Clancy RR. The contribution of EEG to the understanding of neonatal seizures. Epilepsia.\u20081996;37(suppl 1):S52\u2013S59","DOI":"10.1111\/j.1528-1157.1996.tb06022.x"},{"key":"2026032013121837400_R27","doi-asserted-by":"crossref","unstructured":"Painter MJ, Alvin J. Neonatal seizures. Curr Treat Options Neurol.\u20082001;3:237\u2013248","DOI":"10.1007\/s11940-001-0005-x"},{"key":"2026032013121837400_R28","doi-asserted-by":"crossref","unstructured":"Staley K. Enhancement of the excitatory actions of GABA by barbiturates and benzodiazepines. Neurosci Lett.\u20081992;146:105\u2013107","DOI":"10.1016\/0304-3940(92)90183-8"},{"key":"2026032013121837400_R29","doi-asserted-by":"crossref","unstructured":"Clancy R, Legido A, Lewis D. Occult neonatal seizures. Epilepsia.\u20081988;29:256\u2013261","DOI":"10.1111\/j.1528-1157.1988.tb03715.x"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/Supplement_1\/S23\/79899\/Summary-Proceedings-From-the-Neurology-Group-on","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/Supplement_1\/S23\/79899\/Summary-Proceedings-From-the-Neurology-Group-on","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T17:12:24Z","timestamp":1774026744000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/117\/Supplement_1\/S23\/79899\/Summary-Proceedings-From-the-Neurology-Group-on"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3,1]]},"references-count":29,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2006,3,1]]},"published-print":{"date-parts":[[2006,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-0620d","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,3,1]]}}}